As of 2025-05-17, the Intrinsic Value of Regenicin Inc (RGIN) is -0.03 USD. This RGIN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.00 USD, the upside of Regenicin Inc is -3,037,760.00%.
Based on its market price of 0.00 USD and our intrinsic valuation, Regenicin Inc (RGIN) is overvalued by 3,037,760.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.03 - -0.03 | -0.03 | -3,037,760.00% |
| P/E | (0.02) - (0.03) | (0.02) | -2278344.7% |
| DDM - Stable | (0.00) - (1.43) | (0.71) | -71398979.3% |
| DDM - Multi | (0.00) - (0.75) | (0.00) | -14456.5% |
| Market Cap (mil) | 0.00 |
| Beta | -96.99 |
| Outstanding shares (mil) | 153.48 |
| Enterprise Value (mil) | -10.24 |
| Market risk premium | 4.60% |
| Cost of Equity | 595.14% |
| Cost of Debt | 5.00% |
| WACC | 3.81% |